Clinical Trials on Expanded-spectrum Beta-lactamase Producing ESBL

Total 7 results

Kaleido Biosciences

Terminated

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms (VITORA)

Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Deescalating Carbapenems in Hospital Setting (CARBEPARGNE)

Urinary Infection | Digestive Infection | Biliary Infection | Expanded-spectrum Beta-lactamase Producing ESBL
University of Bordeaux

Unknown

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection (Microbe)

Critical Illness | Microbial Colonization | Extended Spectrum Beta-Lactamase Producing Bacteria Infection

France
University Hospital, Basel, Switzerland
Gebert Rüf-Stiftung

Active, not recruiting

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Extended Spectrum Beta Lactamases (ESBL) E. Coli

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Clinical Comparison of Treatment Strategies in AmpC Beta-lactamase Producing Enterobacterales in a Swiss Tertiary Care Hospital (AmpCstratBasel)

Infection With AmpC Beta-lactamase Producing Enterobacterales

Switzerland
Nantes University Hospital

Completed

The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421 (MoBaCo)

Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor

France
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center; National Institute of Allergy and Infectious Diseases... and other collaborators

Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

Antibiotic Resistant Infection | Clostridium Difficile | Antimicrobial Drug Resistance | Carbapenem-Resistant Enterobacteriaceae Infection | Vancomycin Resistant Enterococci Infection | Vancomycin-Resistant Enterococcal Infection | Carbapenem Resistant Bacterial Infection | Extended Spectrum Beta-Lactamase...

United States

Clinical Trials on Expanded-spectrum Beta-lactamase Producing ESBL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations